Abstract
Objective. The purpose of this article is to describe the feasibility and safety of a multidisciplinary approach to imaging-guided axillary staging that facilitates personalized, less invasive surgical management of the axilla through targeted axillary dissection in patients with biopsy-proven nodal metastasis undergoing neoadjuvant chemotherapy. CONCLUSION. Axillary nodal status, critical in breast cancer staging, affects prognosis and treatment. As the paradigm shifts toward minimally invasive therapy, a clip marker is placed in the biopsied metastatic node for patients with N1-N2 disease undergoing neoadjuvant chemotherapy to facilitate targeted axillary dissection of the clipped node. This node is typically localized with a radioactive seed at sentinel lymph node dissection to determine whether further axillary surgery is warranted.
Original language | English (US) |
---|---|
Pages (from-to) | 1372-1379 |
Number of pages | 8 |
Journal | American Journal of Roentgenology |
Volume | 207 |
Issue number | 6 |
DOIs | |
State | Published - Dec 2016 |
Keywords
- Axillary lymph node
- Breast
- Breast cancer
- Radioactive seed
- Targeted axillary dissection
- Ultrasound
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging